麻豆原创 Analysis and Insights: Global Cell Expansion Technologies 麻豆原创
The global Cell Expansion Technologies market is projected to grow from US$ 18060 million in 2023 to US$ 32170 million by 2029, at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period.
Depending upon the type of cell, the global cell expansion market can be broadly split into human cells and animal cells. The human cell can be further divided into stem cells and differentiated cells. Revenue-wise, the human stem cell segment accounts for a dominant share in the market on account of the rising prevalence of various chronic diseases and support provided by the government. In 2016, it held a substantial 58.1% share in the overall revenue in the global cell expansion market.
Geographically, the key segments of the market are Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. Among them, North America is the leading market on account of the concentration of many key players in the region and the increasing research and development in the field. Going forward, North America is slated to slightly pare its market share to hold a 37.7% share in it by 2024. It will still, however, remain the dominant market.
Report Includes
This report presents an overview of global market for Cell Expansion Technologies market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Cell Expansion Technologies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell Expansion Technologies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Expansion Technologies revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Cell Expansion Technologies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Cell Expansion Technologies revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Becton, Dickinson, GE Healthcare, Thermo Fisher Scientific Inc., Corning Inc, Danaher Corp, Merck Millipore, Terumo BCT and STEMCELL Technologies, etc.
By Company
Becton
Dickinson
GE Healthcare
Thermo Fisher Scientific Inc.
Corning Inc
Danaher Corp
Merck Millipore
Terumo BCT
STEMCELL Technologies
Sigma-Aldrich Corp
Miltenyi Biotec
Life Technologies
Replicell
Neximmune
TC Biopharm
Pluristem Therapeutics
ReNeuron
Voria Biomaterials
CellProthera
Cytomatrix
Segment by Type
Reagents
Media
Sera
Disposables
Segment by Application
Clinical diagnostics
Drug discovery and development
Regenerative medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell Expansion Technologies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Expansion Technologies companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Expansion Technologies revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cell Expansion Technologies 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Reagents
1.2.3 Media
1.2.4 Sera
1.2.5 Disposables
1.3 麻豆原创 by Application
1.3.1 Global Cell Expansion Technologies 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical diagnostics
1.3.3 Drug discovery and development
1.3.4 Regenerative medicine
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Expansion Technologies 麻豆原创 Perspective (2018-2029)
2.2 Global Cell Expansion Technologies Growth Trends by Region
2.2.1 Cell Expansion Technologies 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Expansion Technologies Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Cell Expansion Technologies Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Cell Expansion Technologies 麻豆原创 Dynamics
2.3.1 Cell Expansion Technologies Industry Trends
2.3.2 Cell Expansion Technologies 麻豆原创 Drivers
2.3.3 Cell Expansion Technologies 麻豆原创 Challenges
2.3.4 Cell Expansion Technologies 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell Expansion Technologies by Players
3.1.1 Global Cell Expansion Technologies Revenue by Players (2018-2023)
3.1.2 Global Cell Expansion Technologies Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Cell Expansion Technologies 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell Expansion Technologies, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cell Expansion Technologies 麻豆原创 Concentration Ratio
3.4.1 Global Cell Expansion Technologies 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Expansion Technologies Revenue in 2022
3.5 Global Key Players of Cell Expansion Technologies Head office and Area Served
3.6 Global Key Players of Cell Expansion Technologies, Product and Application
3.7 Global Key Players of Cell Expansion Technologies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Expansion Technologies Breakdown Data by Type
4.1 Global Cell Expansion Technologies Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Cell Expansion Technologies Forecasted 麻豆原创 Size by Type (2024-2029)
5 Cell Expansion Technologies Breakdown Data by Application
5.1 Global Cell Expansion Technologies Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Cell Expansion Technologies Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Cell Expansion Technologies 麻豆原创 Size (2018-2029)
6.2 North America Cell Expansion Technologies 麻豆原创 Size by Type
6.2.1 North America Cell Expansion Technologies 麻豆原创 Size by Type (2018-2023)
6.2.2 North America Cell Expansion Technologies 麻豆原创 Size by Type (2024-2029)
6.2.3 North America Cell Expansion Technologies 麻豆原创 Share by Type (2018-2029)
6.3 North America Cell Expansion Technologies 麻豆原创 Size by Application
6.3.1 North America Cell Expansion Technologies 麻豆原创 Size by Application (2018-2023)
6.3.2 North America Cell Expansion Technologies 麻豆原创 Size by Application (2024-2029)
6.3.3 North America Cell Expansion Technologies 麻豆原创 Share by Application (2018-2029)
6.4 North America Cell Expansion Technologies 麻豆原创 Size by Country
6.4.1 North America Cell Expansion Technologies 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Cell Expansion Technologies 麻豆原创 Size by Country (2018-2023)
6.4.3 North America Cell Expansion Technologies 麻豆原创 Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cell Expansion Technologies 麻豆原创 Size (2018-2029)
7.2 Europe Cell Expansion Technologies 麻豆原创 Size by Type
7.2.1 Europe Cell Expansion Technologies 麻豆原创 Size by Type (2018-2023)
7.2.2 Europe Cell Expansion Technologies 麻豆原创 Size by Type (2024-2029)
7.2.3 Europe Cell Expansion Technologies 麻豆原创 Share by Type (2018-2029)
7.3 Europe Cell Expansion Technologies 麻豆原创 Size by Application
7.3.1 Europe Cell Expansion Technologies 麻豆原创 Size by Application (2018-2023)
7.3.2 Europe Cell Expansion Technologies 麻豆原创 Size by Application (2024-2029)
7.3.3 Europe Cell Expansion Technologies 麻豆原创 Share by Application (2018-2029)
7.4 Europe Cell Expansion Technologies 麻豆原创 Size by Country
7.4.1 Europe Cell Expansion Technologies 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Cell Expansion Technologies 麻豆原创 Size by Country (2018-2023)
7.4.3 Europe Cell Expansion Technologies 麻豆原创 Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell Expansion Technologies 麻豆原创 Size (2018-2029)
8.2 China Cell Expansion Technologies 麻豆原创 Size by Type
8.2.1 China Cell Expansion Technologies 麻豆原创 Size by Type (2018-2023)
8.2.2 China Cell Expansion Technologies 麻豆原创 Size by Type (2024-2029)
8.2.3 China Cell Expansion Technologies 麻豆原创 Share by Type (2018-2029)
8.3 China Cell Expansion Technologies 麻豆原创 Size by Application
8.3.1 China Cell Expansion Technologies 麻豆原创 Size by Application (2018-2023)
8.3.2 China Cell Expansion Technologies 麻豆原创 Size by Application (2024-2029)
8.3.3 China Cell Expansion Technologies 麻豆原创 Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cell Expansion Technologies 麻豆原创 Size (2018-2029)
9.2 Asia Cell Expansion Technologies 麻豆原创 Size by Type
9.2.1 Asia Cell Expansion Technologies 麻豆原创 Size by Type (2018-2023)
9.2.2 Asia Cell Expansion Technologies 麻豆原创 Size by Type (2024-2029)
9.2.3 Asia Cell Expansion Technologies 麻豆原创 Share by Type (2018-2029)
9.3 Asia Cell Expansion Technologies 麻豆原创 Size by Application
9.3.1 Asia Cell Expansion Technologies 麻豆原创 Size by Application (2018-2023)
9.3.2 Asia Cell Expansion Technologies 麻豆原创 Size by Application (2024-2029)
9.3.3 Asia Cell Expansion Technologies 麻豆原创 Share by Application (2018-2029)
9.4 Asia Cell Expansion Technologies 麻豆原创 Size by Region
9.4.1 Asia Cell Expansion Technologies 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Cell Expansion Technologies 麻豆原创 Size by Region (2018-2023)
9.4.3 Asia Cell Expansion Technologies 麻豆原创 Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size (2018-2029)
10.2 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cell Expansion Technologies 麻豆原创 Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Becton
11.1.1 Becton Company Details
11.1.2 Becton Business Overview
11.1.3 Becton Cell Expansion Technologies Introduction
11.1.4 Becton Revenue in Cell Expansion Technologies Business (2018-2023)
11.1.5 Becton Recent Developments
11.2 Dickinson
11.2.1 Dickinson Company Details
11.2.2 Dickinson Business Overview
11.2.3 Dickinson Cell Expansion Technologies Introduction
11.2.4 Dickinson Revenue in Cell Expansion Technologies Business (2018-2023)
11.2.5 Dickinson Recent Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Cell Expansion Technologies Introduction
11.3.4 GE Healthcare Revenue in Cell Expansion Technologies Business (2018-2023)
11.3.5 GE Healthcare Recent Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Details
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Cell Expansion Technologies Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Cell Expansion Technologies Business (2018-2023)
11.4.5 Thermo Fisher Scientific Inc. Recent Developments
11.5 Corning Inc
11.5.1 Corning Inc Company Details
11.5.2 Corning Inc Business Overview
11.5.3 Corning Inc Cell Expansion Technologies Introduction
11.5.4 Corning Inc Revenue in Cell Expansion Technologies Business (2018-2023)
11.5.5 Corning Inc Recent Developments
11.6 Danaher Corp
11.6.1 Danaher Corp Company Details
11.6.2 Danaher Corp Business Overview
11.6.3 Danaher Corp Cell Expansion Technologies Introduction
11.6.4 Danaher Corp Revenue in Cell Expansion Technologies Business (2018-2023)
11.6.5 Danaher Corp Recent Developments
11.7 Merck Millipore
11.7.1 Merck Millipore Company Details
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Cell Expansion Technologies Introduction
11.7.4 Merck Millipore Revenue in Cell Expansion Technologies Business (2018-2023)
11.7.5 Merck Millipore Recent Developments
11.8 Terumo BCT
11.8.1 Terumo BCT Company Details
11.8.2 Terumo BCT Business Overview
11.8.3 Terumo BCT Cell Expansion Technologies Introduction
11.8.4 Terumo BCT Revenue in Cell Expansion Technologies Business (2018-2023)
11.8.5 Terumo BCT Recent Developments
11.9 STEMCELL Technologies
11.9.1 STEMCELL Technologies Company Details
11.9.2 STEMCELL Technologies Business Overview
11.9.3 STEMCELL Technologies Cell Expansion Technologies Introduction
11.9.4 STEMCELL Technologies Revenue in Cell Expansion Technologies Business (2018-2023)
11.9.5 STEMCELL Technologies Recent Developments
11.10 Sigma-Aldrich Corp
11.10.1 Sigma-Aldrich Corp Company Details
11.10.2 Sigma-Aldrich Corp Business Overview
11.10.3 Sigma-Aldrich Corp Cell Expansion Technologies Introduction
11.10.4 Sigma-Aldrich Corp Revenue in Cell Expansion Technologies Business (2018-2023)
11.10.5 Sigma-Aldrich Corp Recent Developments
11.11 Miltenyi Biotec
11.11.1 Miltenyi Biotec Company Details
11.11.2 Miltenyi Biotec Business Overview
11.11.3 Miltenyi Biotec Cell Expansion Technologies Introduction
11.11.4 Miltenyi Biotec Revenue in Cell Expansion Technologies Business (2018-2023)
11.11.5 Miltenyi Biotec Recent Developments
11.12 Life Technologies
11.12.1 Life Technologies Company Details
11.12.2 Life Technologies Business Overview
11.12.3 Life Technologies Cell Expansion Technologies Introduction
11.12.4 Life Technologies Revenue in Cell Expansion Technologies Business (2018-2023)
11.12.5 Life Technologies Recent Developments
11.13 Replicell
11.13.1 Replicell Company Details
11.13.2 Replicell Business Overview
11.13.3 Replicell Cell Expansion Technologies Introduction
11.13.4 Replicell Revenue in Cell Expansion Technologies Business (2018-2023)
11.13.5 Replicell Recent Developments
11.14 Neximmune
11.14.1 Neximmune Company Details
11.14.2 Neximmune Business Overview
11.14.3 Neximmune Cell Expansion Technologies Introduction
11.14.4 Neximmune Revenue in Cell Expansion Technologies Business (2018-2023)
11.14.5 Neximmune Recent Developments
11.15 TC Biopharm
11.15.1 TC Biopharm Company Details
11.15.2 TC Biopharm Business Overview
11.15.3 TC Biopharm Cell Expansion Technologies Introduction
11.15.4 TC Biopharm Revenue in Cell Expansion Technologies Business (2018-2023)
11.15.5 TC Biopharm Recent Developments
11.16 Pluristem Therapeutics
11.16.1 Pluristem Therapeutics Company Details
11.16.2 Pluristem Therapeutics Business Overview
11.16.3 Pluristem Therapeutics Cell Expansion Technologies Introduction
11.16.4 Pluristem Therapeutics Revenue in Cell Expansion Technologies Business (2018-2023)
11.16.5 Pluristem Therapeutics Recent Developments
11.17 ReNeuron
11.17.1 ReNeuron Company Details
11.17.2 ReNeuron Business Overview
11.17.3 ReNeuron Cell Expansion Technologies Introduction
11.17.4 ReNeuron Revenue in Cell Expansion Technologies Business (2018-2023)
11.17.5 ReNeuron Recent Developments
11.18 Voria Biomaterials
11.18.1 Voria Biomaterials Company Details
11.18.2 Voria Biomaterials Business Overview
11.18.3 Voria Biomaterials Cell Expansion Technologies Introduction
11.18.4 Voria Biomaterials Revenue in Cell Expansion Technologies Business (2018-2023)
11.18.5 Voria Biomaterials Recent Developments
11.19 CellProthera
11.19.1 CellProthera Company Details
11.19.2 CellProthera Business Overview
11.19.3 CellProthera Cell Expansion Technologies Introduction
11.19.4 CellProthera Revenue in Cell Expansion Technologies Business (2018-2023)
11.19.5 CellProthera Recent Developments
11.20 Cytomatrix
11.20.1 Cytomatrix Company Details
11.20.2 Cytomatrix Business Overview
11.20.3 Cytomatrix Cell Expansion Technologies Introduction
11.20.4 Cytomatrix Revenue in Cell Expansion Technologies Business (2018-2023)
11.20.5 Cytomatrix Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Becton
Dickinson
GE Healthcare
Thermo Fisher Scientific Inc.
Corning Inc
Danaher Corp
Merck Millipore
Terumo BCT
STEMCELL Technologies
Sigma-Aldrich Corp
Miltenyi Biotec
Life Technologies
Replicell
Neximmune
TC Biopharm
Pluristem Therapeutics
ReNeuron
Voria Biomaterials
CellProthera
Cytomatrix
听
听
*If Applicable.
